title: Media report of rare rhabdomyolysis cases seems to have triggered reluctance among some New Zealanders to use statins.
authors.forename: Patrick A
authors.initials: PA
authors.lastname: Gladding
authors.forename: Andrew
authors.initials: A
authors.lastname: Kerr
authors.forename: Colin
authors.initials: C
authors.lastname: Edwards
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects*; D000069059:Atorvastatin; D006266:Health Education / Q000379:methods; D007722:Health Knowledge, Attitudes, Practice; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D008402:Mass Media; D009520:New Zealand; D011758:Pyrroles / Q000627:therapeutic use; D012206:Rhabdomyolysis / Q000139:chemically induced*; D019821:Simvastatin / Q000627:therapeutic use
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin; D019821:Simvastatin